![](https://www.microbiometimes.com/wp-content/uploads/2018/05/panorama-3094696_960_720-326x245.jpg)
Finance
Evolve BioSystems Announces $40 Million Series C Financing to Expand its Flagship Infant Probiotic Product Evivo
Evolve BioSystems, Inc., the leading infant gut microbiome company, today announced that it has completed a $40 million Series C round of funding co-led by the Bill & Melinda Gates Foundation, and Horizons Ventures, the […]